These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30204260)

  • 21. Melanin, melatonin, melanocyte-stimulating hormone, and the susceptibility to autoimmune demyelination: a rationale for light therapy in multiple sclerosis.
    Constantinescu CS
    Med Hypotheses; 1995 Nov; 45(5):455-8. PubMed ID: 8748085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis is not a disease of the immune system.
    Corthals AP
    Q Rev Biol; 2011 Dec; 86(4):287-321. PubMed ID: 22384749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis: multiple etiologies, multiple genes?
    Tienari PJ
    Ann Med; 1994 Aug; 26(4):259-69. PubMed ID: 7524545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic mechanisms and experimental models of multiple sclerosis.
    Slavin A; Kelly-Modis L; Labadia M; Ryan K; Brown ML
    Autoimmunity; 2010 Nov; 43(7):504-13. PubMed ID: 20380590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental factors and their interactions with risk genotypes in MS susceptibility.
    Hedström AK; Alfredsson L; Olsson T
    Curr Opin Neurol; 2016 Jun; 29(3):293-8. PubMed ID: 27035899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple Sclerosis: Basic and Clinical.
    Buzzard K; Chan WH; Kilpatrick T; Murray S
    Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemically altered myelin triggers autoimmune demyelination.
    Caprariello AV; Rogers JA; Morgan ML; Hoghooghi V; Plemel JR; Koebel A; Tsutsui S; Dunn JF; Kotra LP; Ousman SS; Wee Yong V; Stys PK
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5528-5533. PubMed ID: 29728463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of costimulation in autoimmune demyelination.
    Racke MK; Ratts RB; Arredondo L; Perrin PJ; Lovett-Racke A
    J Neuroimmunol; 2000 Jul; 107(2):205-15. PubMed ID: 10854658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease.
    Eslahi M; Nematbakhsh N; Dastmalchi N; Teimourian S; Safaralizadeh R
    CNS Neurol Disord Drug Targets; 2023; 22(3):381-393. PubMed ID: 35043771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Multiple Sclerosis: Genes, Environment, and a Comprehensive Therapeutic Approach.
    Cappa R; Theroux L; Brenton JN
    Pediatr Neurol; 2017 Oct; 75():17-28. PubMed ID: 28843454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
    Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
    Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention.
    Rito Y; Torre-Villalvazo I; Flores J; Rivas V; Corona T
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):8-15. PubMed ID: 26915659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
    Wexler AG; Frielle C; Berry G; Budgeon LR; Baccon J; Christensen ND; Waldner H
    J Neuroimmunol; 2013 Feb; 255(1-2):60-9. PubMed ID: 23269203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential role of calcifying nanoparticles in the etiology of multiple sclerosis.
    Can Demirdöğen B
    Med Hypotheses; 2019 Jul; 128():25-27. PubMed ID: 31203904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons from the neuropathology of atypical forms of multiple sclerosis.
    Stadelmann C; Brück W
    Neurol Sci; 2004 Nov; 25 Suppl 4():S319-22. PubMed ID: 15727225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the aetiology and pathogenesis of multiple sclerosis.
    Ewing C; Bernard CC
    Immunol Cell Biol; 1998 Feb; 76(1):47-54. PubMed ID: 9553776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.
    Hayes CE; Donald Acheson E
    Med Hypotheses; 2008; 71(1):85-90. PubMed ID: 18387750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.